Current Value
$57.461 Year Return
Current Value
$57.461 Year Return
Double maintains 3 strategies that include BMRN - BioMarin Pharmaceutical, Inc.
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| IQV | 47.97% | $28.48B | -20.39% | 0.00% |
| TMO | 47.08% | $161.48B | -20.14% | 0.38% |
| ITOS | 46.09% | $388.86M | -31.26% | 0.00% |
| AAPL | 44.71% | $3.17T | -4.11% | 0.48% |
| OBDC | 44.22% | $7.41B | -5.76% | 10.16% |
| AMGN | 44.22% | $159.62B | -4.05% | 3.12% |
| BIIB | 44.14% | $19.52B | -40.70% | 0.00% |
| ARCC | 43.79% | $15.07B | - | 8.60% |
| SLRC | 43.78% | - | - | 10.19% |
| MTD | 43.69% | $25.06B | -10.96% | 0.00% |
| NOVT | 43.45% | $4.78B | -17.12% | 0.00% |
| BRKR | 43.15% | $6.43B | -31.33% | 0.47% |
| RVTY | 43.00% | $11.89B | -1.62% | 0.28% |
| IONS | 42.92% | $6.94B | -4.41% | 0.00% |
| EFX | 42.78% | $32.59B | +9.13% | 0.64% |
| DD | 42.53% | $30.53B | -7.88% | 2.15% |
| A | 42.03% | $34.28B | -4.34% | 1.00% |
| TECH | 41.62% | $8.34B | -25.57% | 0.60% |
| LYB | 41.55% | $20.11B | -34.27% | 8.60% |
| QRVO | 41.52% | $8.20B | -24.63% | 0.00% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BBH | 58.78% | $330.62M | 0.35% |
| IBB | 57.32% | $5.26B | 0.45% |
| PBE | 57.02% | $223.19M | 0.58% |
| FBT | 55.94% | $1.01B | 0.54% |
| VHT | 54.10% | $15.35B | 0.09% |
| XBI | 53.88% | $4.82B | 0.35% |
| FHLC | 53.86% | $2.44B | 0.084% |
| IYH | 53.35% | $2.73B | 0.39% |
| IXJ | 52.35% | $3.75B | 0.41% |
| RSPH | 52.24% | $729.81M | 0.4% |
| XLV | 52.16% | $34.28B | 0.09% |
| MOAT | 50.93% | $12.66B | 0.47% |
| GNOM | 50.47% | $44.57M | 0.5% |
| PINK | 50.40% | $130.57M | 0.5% |
| XPH | 49.59% | $147.96M | 0.35% |
| PPH | 49.38% | $610.46M | 0.36% |
| FXH | 49.33% | $903.07M | 0.62% |
| IHE | 49.18% | $550.45M | 0.39% |
| JEPI | 48.96% | $40.99B | 0.35% |
| BALT | 48.19% | $1.49B | 0.69% |
Yahoo
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) said today that it completed the previously announced agreement to acquire Inozyme Pharma, Inc. (Nasdaq: INZY) for $4.00 per share in an all-cash transaction worth approximately $270 million. The acquisition will strengthen BioMarin's enzyme therapies portfolio, adding a late-stage enzyme replacement therapy, INZ-701. The medicine is currently being developed for the treatment of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) Deficiency, a
Finnhub
BioMarin Pharmaceutical Inc. dropped from Russell 1000 Value-Defensive Index...
Finnhub
BioMarin Pharmaceutical Inc. dropped from Russell 1000 Defensive Index...
Yahoo
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the most undervalued US stocks according to analysts. On June 24, BioMarin Pharmaceutical Inc. presented new 5-year data from its Phase 3 GENEr8-1 trial at the 33rd Congress of the International Society on Thrombosis and Haemostasis/ISTH in Washington, D.C., which took place from June 21 to 25. The […]
Yahoo
BioMarin’s first quarter performance was shaped by robust global demand for its rare disease therapies, particularly VOXZOGO, which continued its double-digit growth trajectory. Management attributed the healthy top-line results to strong patient uptake across 49 countries and the expanding footprint of its enzyme therapies, including notable gains for PALYNZIQ and ALDURAZYME. CEO Alexander Hardy explained, "These results pave the way for record full year performance in 2025 and boost cash gener
Finnhub
SAN RAFAEL - BioMarin Pharmaceutical Inc. announced new data underscoring the long-term efficacy and safety of ROCTAVIAN were presented at the 33rd Congress of the International Society on Thrombosis...
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| TAIL | -43.49% | $99.63M | 0.59% |
| VIXY | -41.04% | $164.54M | 0.85% |
| FTSD | -18.93% | $231.81M | 0.25% |
| IVOL | -18.32% | $347.03M | 1.02% |
| XONE | -15.83% | $625.28M | 0.03% |
| FXY | -15.58% | $816.38M | 0.4% |
| BTAL | -14.95% | $296.22M | 1.43% |
| ULST | -14.70% | $654.75M | 0.2% |
| GBIL | -13.86% | $6.37B | 0.12% |
| TPMN | -13.68% | $30.70M | 0.65% |
| SPTS | -13.65% | $5.80B | 0.03% |
| CLIP | -12.27% | $1.51B | 0.07% |
| TBLL | -11.57% | $2.13B | 0.08% |
| FXE | -11.25% | $568.94M | 0.4% |
| BWX | -10.18% | $1.53B | 0.35% |
| UTWO | -9.71% | $379.52M | 0.15% |
| STOT | -9.54% | $254.07M | 0.45% |
| VGSH | -9.45% | $22.80B | 0.03% |
| IBTG | -8.98% | $1.92B | 0.07% |
| SHV | -8.95% | $20.64B | 0.15% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| SCHQ | -0.01% | $758.74M | 0.03% |
| GOVI | 0.06% | $929.28M | 0.15% |
| SHYD | 0.13% | $332.63M | 0.35% |
| CARY | -0.20% | $347.36M | 0.8% |
| VGLT | 0.21% | $9.85B | 0.04% |
| JBND | 0.21% | $2.32B | 0.25% |
| BNDW | 0.23% | $1.29B | 0.05% |
| SPTL | -0.28% | $11.44B | 0.03% |
| TOTL | -0.34% | $3.84B | 0.55% |
| LDUR | -0.40% | $929.65M | 0.5% |
| GOVZ | 0.41% | $272.00M | 0.1% |
| DBE | -0.43% | $52.20M | 0.77% |
| BSV | -0.53% | $38.39B | 0.03% |
| ZROZ | 0.60% | $1.52B | 0.15% |
| BNO | 0.63% | $103.79M | 1% |
| USL | 0.65% | $42.23M | 0.85% |
| FLMI | -0.69% | $725.99M | 0.3% |
| FMHI | 0.70% | $754.85M | 0.7% |
| TLH | 0.74% | $11.52B | 0.15% |
| SHY | -0.78% | $23.83B | 0.15% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| EDSA | -0.06% | $14.33M | -51.66% | 0.00% |
| MVO | -0.07% | $66.47M | -37.17% | 21.45% |
| CBOE | 0.41% | $24.23B | +35.36% | 1.09% |
| SATS | -0.42% | $8.47B | +60.36% | 0.00% |
| ASND | 0.59% | $10.45B | +29.01% | 0.00% |
| RDUS | 0.62% | $835.63M | +86.59% | 2.53% |
| CLLS | 0.64% | $118.95M | -19.51% | 0.00% |
| ZCMD | 0.74% | $29.55M | -8.59% | 0.00% |
| DRD | 0.77% | $1.18B | +51.33% | 2.03% |
| VSTA | -0.91% | $344.07M | +39.29% | 0.00% |
| RLX | -0.93% | $2.13B | +27.17% | 0.42% |
| RLMD | -0.99% | $19.95M | -80.03% | 0.00% |
| TH | 1.03% | $715.43M | -17.05% | 0.00% |
| VSA | -1.07% | $8.67M | -19.04% | 0.00% |
| GALT | 1.13% | $137.34M | +0.93% | 0.00% |
| AIFU | -1.41% | $6.79B | +102.19% | 0.00% |
| GORV | 1.45% | $27.07M | -91.17% | 0.00% |
| SAVA | 1.49% | $97.10M | -81.34% | 0.00% |
| EVGO | 1.56% | $470.93M | +38.74% | 0.00% |
| PRPO | -1.58% | $17.08M | +125.94% | 0.00% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| TDUP | -10.99% | $895.13M | +358.79% | 0.00% |
| AQB | -10.23% | $2.96M | -53.35% | 0.00% |
| HUSA | -9.00% | $19.66M | -19.53% | 0.00% |
| K | -7.35% | $27.76B | +41.17% | 2.85% |
| VHC | -6.44% | $48.19M | +108.24% | 0.00% |
| STG | -6.22% | $30.78M | -22.51% | 0.00% |
| UUU | -5.22% | $7.17M | +101.30% | 0.00% |
| MKTX | -4.60% | $8.22B | +9.03% | 1.38% |
| DFDV | -4.33% | $300.56M | +2,130.16% | 0.00% |
| PSQH | -4.17% | $98.82M | -36.55% | 0.00% |
| PHYS.U | -3.21% | - | - | 0.00% |
| SYPR | -2.96% | $48.49M | +14.05% | 0.00% |
| NUVL | -2.76% | $5.78B | +11.73% | 0.00% |
| UFI | -2.69% | $92.35M | -10.82% | 0.00% |
| GFI | -1.89% | $21.56B | +57.55% | 2.31% |
| PRPO | -1.58% | $17.08M | +125.94% | 0.00% |
| AIFU | -1.41% | $6.79B | +102.19% | 0.00% |
| VSA | -1.07% | $8.67M | -19.04% | 0.00% |
| RLMD | -0.99% | $19.95M | -80.03% | 0.00% |
| RLX | -0.93% | $2.13B | +27.17% | 0.42% |
